CA Inc., a major supplier of software to federal agencies, paid $45 million to settle a False Claims Act lawsuit by a VSG client who alleged that the company misrepresented to the Government the nature and extent of the pricing discounts that the company was providing to its commercial customers.
VSG’s qui tam lawyers, while in private practice and previously with the Department of Justice, have successfully represented whistleblowers and the government, winning many significant False Claims Act recoveries and qui tam settlements. Our whistleblower lawsuits have received national coverage in the media, including The New York Times, Wall Street Journal, Washington Post, Los Angeles Times, Boston Globe, and 60 Minutes.
The following are summaries of some of our cases.
LifeScan, Inc., a medical device manufacturer, paid $30.6 million to settle allegations in a qui tam lawsuit that it sold defective blood glucose monitors to Medicare patients and failed to report adverse events to the FDA.
EmCare, Inc. paid more than $30 million to settle qui tam claims brought by VSG clients and another set of relators, alleging that EmCare received kickbacks from a major hospital chain in exchange for pressuring hospital emergency room (ER) doctors to increase the rate of ER-to-hospital admissions. EmCare also entered into a confidential settlement with VSG’s client on her unlawful retaliation claim.
Emergency Physicians Billing Service paid over $28.8 million to resolve whistleblower claims in a qui tam lawsuit that it systematically overcharged Medicare for emergency physician services. The settlement followed a trial conducted by qui tam attorney Mr. Vogel, co-counsel, and government counsel that established the defendant’s liability under the False Claims Act.
BlueCross/Blue Shield of Michigan, the fiscal intermediary for Medicare in Michigan, paid more than $27.6 million to settle qui tam whistleblower claims alleging that it cheated on quality control tests in order to misrepresent the quality of the auditing services it was providing for the Medicare program.
New York State paid $27 million to resolve allegations in a whistleblower lawsuit that it submitted false claims for federal funds meant for the training of social service workers.
Inchcape Shipping Services, one of the world’s largest providers of marine support services, agreed to pay $20 million to settle a VSG whistleblower lawsuit accusing Inchcape of overbilling the Navy for services provided to Navy ships in ports around the world. VSG’s clients were awarded $4.4 million, 22% of the settlement proceeds.
Omnicare, Inc. paid more than $20 million to resolve allegations made by a firm qui tam whistleblower client that the pharmacy chain knowingly overbilled the Medicaid programs of Massachusetts and Michigan as a result of its failure to comply with the “usual and customary charge” billing rule.
Motorola, Inc., in what was at the time the largest civil recovery ever by the General Services Administration (GSA), paid $15 million to settle GSA’s claims that the company had submitted false claims for goods sold pursuant to the Multiple Award Schedule.
Pratt & Whitney paid $14.8 million to settle the government’s allegations that it violated the False Claims Act by diverting Foreign Military Sales Program funds to unauthorized purposes, including payments to an Israeli Brigadier General.
Ivax Pharmaceuticals a manufacturer of generic medications, paid $14 million to resolve qui tam whistleblower claims by a firm client that it paid kickbacks to become Omnicare’s exclusive supplier of certain generic medications.
UroCor, Inc., and Dianon Systems, Inc. medical laboratories, paid $9 million and $4.8 million, respectively, to resolve claims in qui tam whistleblower lawsuits alleging that they billed Medicare for medically unnecessary lab tests that physicians did not know they were ordering.